MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$10,434K
(67.50%↑ Y/Y)
Net loss
-$10,385K
(67.63%↑ Y/Y)
Unrealized gain on
marketable securities, net...
-$49K
(-113.04%↓ Y/Y)
Other income, net
$3,792K
(50.42%↑ Y/Y)
Loss from operations
-$14,177K
(59.03%↑ Y/Y)
Revenue
$4,580K
Total operating
expenses
$18,757K
(-45.80%↓ Y/Y)
Research and development
$13,601K
(-52.80%↓ Y/Y)
General and
administrative
$5,156K
(-10.95%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)